Renal Cancer - Results from #9080

CURy 2011 - Selecting targeted agents for the treatment of advanced RCC - Slide Presentation March 22, 2011

Ability and utility of diffusion-weighted MRI with different b values in the evaluation of benign and malignant renal lesions - Abstract March 21, 2011

Long-term survival in a patient with node-positive adult-onset Xp11.2 translocation renal cell carcinoma - Abstract March 21, 2011

Discrepancy between radiological and pathological size of renal masses - Abstract March 21, 2011

Clear cell renal cell carcinoma with osseous metaplasia: A case report - Abstract March 18, 2011

Oncological outcomes in patients undergoing radical nephrectomy and vena cava thrombectomy for renal cell carcinoma with venous extension: A single-centre experience - Abstract March 17, 2011

Update on targeted therapies for clear cell renal cell carcinoma - Abstract March 17, 2011

Three cases of renal cell carcinoma with sarcomatoid differentiation - Abstract March 16, 2011

Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: A large open-label study in diverse community settings - Abstract March 16, 2011

A case report of retroaortic left renal vein with tumor thrombus of renal cell carcinoma - Abstract March 16, 2011

Fine-needle aspiration of renal cell carcinoma: Is accurate Fuhrman grading possible on cytologic material? - Abstract March 15, 2011

Laparoendoscopic single-site nephrectomy using a modified umbilical incision and a home-made transumbilical port - Abstract March 15, 2011

Insulin-like growth factor binding protein-3 (IGFBP-3) gene variants are associated with renal cell carcinoma - Abstract March 14, 2011

Tumor size is a potential predictor of response to tyrosine kinase inhibitors in renal cell cancer - Abstract March 14, 2011

Present and future therapeutic options for locally advanced and metastatic renal cell carcinoma - Abstract March 11, 2011

Comparison of four early posttherapy imaging changes (EPTIC; RECIST 1.0, tumor shrinkage, computed tomography tumor density, Choi criteria) in assessing outcome to vascular endothelial growth factor March 11, 2011

A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802 - Abstract March 10, 2011

Combined immunochemotherapy in selected patients with metastatic renal cell carcinoma: HLA class II genotype can help to predict response to therapy - Abstract March 10, 2011

Clinicopathological outcomes of clinical T1a renal cell carcinoma by tumor size - Abstract March 9, 2011

Non-clear cell renal cell carcinoma: How new biological insight may lead to new therapeutic modalities - Abstract March 9, 2011

Page 455 of 456